Executive Director, Scientific Affairs (EDSA) - Pulmonary Hypertension

Job Description

Our Medical Affairs team advances patient care by engaging in scientific exchange with external medical experts and industry professionals ensuring the scientific value of our products is realized. We engage and train internal employees to ensure that they thoroughly comprehend the science behind the medicine and review further unmet medical needs to bolster collaboration and further differentiate our portfolio. 

The Executive Director Scientific Affairs (EDSA) for Pulmonary Hypertension will focus on efforts to maximize meaningful bi-directional scientific exchange by incorporating external scientific input into our Research & Development laboratories strategy to impact how our Company discovers, develops, and commercializes new drugs in cardiovascular disease and pulmonary hypertension (will include heart failure, atherosclerosis, thrombosis and other). 

The Executive Director will join the relevant Research & Development late-stage Product Development Teams (PDTs) clinical sub teams and chair the Company investigator-initiated studies programs in Pulmonary Hypertension disease.  The Executive Director, Scientific Affairs (EDSA) maximizes meaningful bi-directional scientific exchange with the worldwide clinical and academic community to positively impact Research and Development (R&D) strategy for new medicines and to improve outcomes for patients.

Role summary:

• Leads a large investigator-initiated studies program in partnership with late-stage development teams in Medical Affairs while also supporting early-stage development teams. 

• Drive a credible and informed scientific dialogue with global Scientific Leaders in Pulmonary Hypertension related areas (responsible for collaborative partnerships with key global Scientific Leaders across all regions relevant to strategic priorities, both US and Ex-US)

• Partner with colleagues in Research & Development GCD (Global Clinical Development) to execute the Scientific Leadership strategy in alignment with the end-to-end pulmonary hypertension scientific strategy

• Partners with Medical Affairs leadership to develop the global Value Evidence and Medical Planning strategy across designated therapeutic areas.

• The EDSA has a key role at major congresses, including, but not limited to, facilitating daily debriefs, engaging with Scientific Leaders (SLs), and producing comprehensive congress summary reports.

• Responsibility for both internal and external commitments, with an emphasis on external scientific engagements

Primary Responsibilities:

• Leads investigator initiated studies program for pulmonary hypertension therapeutic area.

• Develop individual relationships with global scientific leaders in Cardiovascular and Pulmonology science through scientific dialogue pertinent to our Company's interests

• Organize, chair or participate in a variety of scientific input forums (Research & Development consultants meetings and scientific advisory boards) to gain specific input from external scientists and physicians to support drug development activities within the Research & Development division

• Chair the Company Investigator Initiated Studies Review Committee- responsible for reviewing external investigator initiated scientific study protocols encompassing both pre-clinical and clinical work

• Provides subject matter expertise for Product Development and Publications teams and facilitates cross-functional communication and collaboration in pursuit of our company’s R&D strategy 

• Coordinate, lead/participate in Research & Development activities at key global scientific congresses including collection of competitive intelligence and creation of a written Executive Summary

• Lead cross-functional Cardiovascular Global Scientific Medical and Research Teams

• Attend and actively participate in both Product Development Clinical sub-teams, Value Evidence sub-teams, and  Publications sub-teams

• Ensure partnerships with leaders of key professional societies and organizations as well as major academic medical centers

• Ensure existing Scientific Leaders relationship with Company scientists are sustained and strengthened via appropriate Scientific Leader engagement plans

• Sustains our Company’s scientific credibility and fosters and develops relationships with global leaders, major academic medical centers, and key professional societies and organizations through relevant bi-directional scientific exchange

• Maintain credibility by being on the leading edge on state of science and shifts in clinical and treatment paradigms

• Coordinate relationships across divi